Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APOTHECARY AF Study
NCT04907825Phase 4Completed
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Mar 2023
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in Atrial fibrillation (AFib), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Proportion of patients receiving guideline concordant OAC therapy at 12 months. Started Mar 2023; status: completed.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04907825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04907825.